The Valley Desk

NCT02686762 · Interventional trial

Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis

Overall registry status Completed

Phase 2

Conditions Fibrosis, Liver Diseases, Non-alcoholic Steatohepatitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov